JPWO2009084680A1 - 金ナノ粒子組成物、dnaチップ、近赤外線吸収材、ドラッグデリバリーシステム(dds)用薬物保持体、着色剤、バイオセンサー、化粧品、生体内診断用組成物および治療用組成物 - Google Patents
金ナノ粒子組成物、dnaチップ、近赤外線吸収材、ドラッグデリバリーシステム(dds)用薬物保持体、着色剤、バイオセンサー、化粧品、生体内診断用組成物および治療用組成物 Download PDFInfo
- Publication number
- JPWO2009084680A1 JPWO2009084680A1 JP2009548115A JP2009548115A JPWO2009084680A1 JP WO2009084680 A1 JPWO2009084680 A1 JP WO2009084680A1 JP 2009548115 A JP2009548115 A JP 2009548115A JP 2009548115 A JP2009548115 A JP 2009548115A JP WO2009084680 A1 JPWO2009084680 A1 JP WO2009084680A1
- Authority
- JP
- Japan
- Prior art keywords
- gold nanoparticle
- nanoparticle composition
- composition according
- gold
- organic ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000010931 gold Substances 0.000 title claims abstract description 115
- 229910052737 gold Inorganic materials 0.000 title claims abstract description 115
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 113
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 111
- 239000000203 mixture Substances 0.000 title claims abstract description 95
- 238000000018 DNA microarray Methods 0.000 title claims description 7
- 238000001727 in vivo Methods 0.000 title claims description 7
- 239000002537 cosmetic Substances 0.000 title claims description 6
- 238000012377 drug delivery Methods 0.000 title claims description 6
- 239000003086 colorant Substances 0.000 title claims description 5
- 239000003937 drug carrier Substances 0.000 title claims description 5
- 230000001225 therapeutic effect Effects 0.000 title claims description 4
- 239000011358 absorbing material Substances 0.000 title description 6
- -1 biosensor Substances 0.000 title description 3
- 238000010521 absorption reaction Methods 0.000 claims abstract description 33
- 239000013110 organic ligand Substances 0.000 claims abstract description 19
- 150000004985 diamines Chemical class 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 125000005647 linker group Chemical group 0.000 claims description 10
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 10
- 125000001424 substituent group Chemical group 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 229920003026 Acene Polymers 0.000 claims description 2
- 239000006096 absorbing agent Substances 0.000 claims description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- 150000002343 gold Chemical class 0.000 abstract description 4
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 239000011148 porous material Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 description 15
- 238000000862 absorption spectrum Methods 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000003973 paint Substances 0.000 description 6
- 239000000032 diagnostic agent Substances 0.000 description 5
- 229940039227 diagnostic agent Drugs 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- BEKFRNOZJSYWKZ-UHFFFAOYSA-N 4-[2-(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(N)C=C1 BEKFRNOZJSYWKZ-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 238000003917 TEM image Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- UVUCUHVQYAPMEU-UHFFFAOYSA-N 3-[2-(3-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound NC1=CC=CC(C(C=2C=C(N)C=CC=2)(C(F)(F)F)C(F)(F)F)=C1 UVUCUHVQYAPMEU-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 230000008499 blood brain barrier function Effects 0.000 description 3
- 210000001218 blood-brain barrier Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000007772 electrode material Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000003365 glass fiber Substances 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 230000001678 irradiating effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- NSGXIBWMJZWTPY-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropane Chemical compound FC(F)(F)CC(F)(F)F NSGXIBWMJZWTPY-UHFFFAOYSA-N 0.000 description 2
- 206010020843 Hyperthermia Diseases 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 230000036031 hyperthermia Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MSTZGVRUOMBULC-UHFFFAOYSA-N 2-amino-4-[2-(3-amino-4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]phenol Chemical group C1=C(O)C(N)=CC(C(C=2C=C(N)C(O)=CC=2)(C(F)(F)F)C(F)(F)F)=C1 MSTZGVRUOMBULC-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/025—Explicitly spheroidal or spherical shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
- A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/10—Metallic powder containing lubricating or binding agents; Metallic powder containing organic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/58—Metal complex; Coordination compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/612—By organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Optics & Photonics (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
2 セル容器
3 近赤外線フィルター
4 導光管
5 照明電源
6 ガラスファイバープローブ
7 温度計測器
Claims (14)
- 球状の金ナノ粒子と、
前記金ナノ粒子に結合する有機リガンド分子と
を含有し、
少なくとも1つの吸収ピークの波長が600nmから1000nmまでの領域内に存在する
金ナノ粒子組成物。 - 前記金ナノ粒子は、塩化金酸溶液中において塩化金酸を還元することによって製造される
請求項1に記載の金ナノ粒子組成物。 - 前記有機リガンド分子は、窒素原子および硫黄原子の少なくとも一方の原子を含有する
請求項1又は2に記載の金ナノ粒子組成物。 - 前記有機リガンド分子は、下記一般式(I)で示される少なくとも1種のジアミンを含む
請求項3に記載の金ナノ粒子組成物。
- 請求項1から6のいずれかに記載の金ナノ粒子組成物を含むDNAチップ。
- 請求項1から6のいずれかに記載の金ナノ粒子組成物を含む近赤外線吸収材。
- 請求項1から6のいずれかに記載の金ナノ粒子組成物を含むドラッグデリバリーシステム用薬物保持体。
- 請求項1から6のいずれかに記載の金ナノ粒子組成物を含む着色剤。
- 請求項1から6のいずれかに記載の金ナノ粒子組成物を含むバイオセンサー。
- 請求項1から6のいずれかに記載の金ナノ粒子組成物を含む化粧品。
- 請求項1から6のいずれかに記載の金ナノ粒子組成物を含む生体内診断用組成物。
- 請求項1から6のいずれかに記載の金ナノ粒子組成物を含む治療用組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009548115A JP5397862B2 (ja) | 2007-12-28 | 2008-12-26 | 金ナノ粒子組成物、dnaチップ、近赤外線吸収材、ドラッグデリバリーシステム(dds)用薬物保持体、着色剤、バイオセンサー、化粧品、生体内診断用組成物および治療用組成物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007338733 | 2007-12-28 | ||
JP2007338733 | 2007-12-28 | ||
PCT/JP2008/073847 WO2009084680A1 (ja) | 2007-12-28 | 2008-12-26 | 金ナノ粒子組成物、dnaチップ、近赤外線吸収材、ドラッグデリバリーシステム(dds)用薬物保持体、着色剤、バイオセンサー、化粧品、生体内診断用組成物および治療用組成物 |
JP2009548115A JP5397862B2 (ja) | 2007-12-28 | 2008-12-26 | 金ナノ粒子組成物、dnaチップ、近赤外線吸収材、ドラッグデリバリーシステム(dds)用薬物保持体、着色剤、バイオセンサー、化粧品、生体内診断用組成物および治療用組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2009084680A1 true JPWO2009084680A1 (ja) | 2011-05-19 |
JP5397862B2 JP5397862B2 (ja) | 2014-01-22 |
Family
ID=40824393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009548115A Expired - Fee Related JP5397862B2 (ja) | 2007-12-28 | 2008-12-26 | 金ナノ粒子組成物、dnaチップ、近赤外線吸収材、ドラッグデリバリーシステム(dds)用薬物保持体、着色剤、バイオセンサー、化粧品、生体内診断用組成物および治療用組成物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100285994A1 (ja) |
EP (1) | EP2241394A1 (ja) |
JP (1) | JP5397862B2 (ja) |
KR (1) | KR20100107437A (ja) |
CN (1) | CN101835556A (ja) |
WO (1) | WO2009084680A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2511028A4 (en) * | 2009-12-11 | 2017-05-24 | Tokyo University Of Science Educational Foundation Administrative Organization | Au-ag core-shell nanorod particles and method for producing same |
CN101974286B (zh) * | 2010-11-22 | 2012-08-22 | 东南大学 | 一种抗近红外辐射节能窗用涂布膜 |
DK3051951T3 (en) | 2013-10-01 | 2019-04-23 | B Braun Surgical Sa | MODIFIED SURFACE capable of having bacteriostatic and bactericidal activity, the method of obtaining it and its use |
CN105535990A (zh) * | 2016-01-08 | 2016-05-04 | 山东大学 | 一种表面亲疏水性质差异化的球形金纳米颗粒阵列及其应用 |
US10145009B2 (en) * | 2017-01-26 | 2018-12-04 | Asm Ip Holding B.V. | Vapor deposition of thin films comprising gold |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006059664A1 (ja) * | 2004-12-03 | 2006-06-08 | Japan Science And Technology Agency | 安定化無機ナノ粒子、安定化無機ナノ粒子群、安定化無機ナノ粒子の製造方法及び安定化無機ナノ粒子の利用方法 |
WO2006075974A1 (en) * | 2005-01-17 | 2006-07-20 | Agency For Science, Technology And Research | Water-soluble nanocrystals and methods of preparing them |
JP2007139612A (ja) * | 2005-11-18 | 2007-06-07 | Fujifilm Corp | 微細構造体、微細構造体の作製方法、ラマン分光法、及び装置 |
WO2007107574A2 (fr) * | 2006-03-20 | 2007-09-27 | Commissariat A L'energie Atomique | Nanoparticules notamment a structure coeur coquille, enrobees |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0025414D0 (en) * | 2000-10-16 | 2000-11-29 | Consejo Superior Investigacion | Nanoparticles |
EP2189232A1 (en) * | 2003-09-05 | 2010-05-26 | Mitsubishi Materials Corporation | Metal microparticle, composition containing the same and process for producing metal microparticle |
JP4512876B2 (ja) | 2003-09-05 | 2010-07-28 | 三菱マテリアル株式会社 | 金属微粒子、金属微粒子を製造する方法及び金属微粒子を含有する組成物等 |
US20060266157A1 (en) * | 2003-09-05 | 2006-11-30 | Dai Nippon Toryo Co., Ltd. | Metal fine particles, composition containing the same, and production method for producing metal fine particles |
JP2005220435A (ja) * | 2003-10-22 | 2005-08-18 | Mitsuboshi Belting Ltd | 金属ナノ粒子及び金属ナノ粒子分散液の製造方法 |
US20050090732A1 (en) | 2003-10-28 | 2005-04-28 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles |
JP2005287507A (ja) * | 2004-03-10 | 2005-10-20 | Japan Science & Technology Agency | カチオン性金ナノ粒子及びポリエチレングリコール修飾カチオン性金ナノ粒子並びにそれらの核酸との複合体 |
JP2005255582A (ja) | 2004-03-10 | 2005-09-22 | Japan Science & Technology Agency | 光照射を用いた遺伝子または薬物導入発現方法 |
CN1980761B (zh) * | 2004-07-08 | 2011-01-26 | 三菱麻铁里亚尔株式会社 | 金属微粒子的制造方法、通过该方法制得的金属微粒子以及含有该金属微粒子而成的组合物、光吸收材料、应用品 |
JP4529160B2 (ja) * | 2004-07-08 | 2010-08-25 | 三菱マテリアル株式会社 | 金属微粒子とその製造方法とその含有組成物ならびにその用途 |
JP4821951B2 (ja) * | 2005-02-23 | 2011-11-24 | 三菱マテリアル株式会社 | ワイヤー状の金微粒子と、その製造方法および含有組成物ならびに用途 |
JP4812370B2 (ja) * | 2005-08-29 | 2011-11-09 | 地方独立行政法人 大阪市立工業研究所 | 貴金属ナノ粒子の製造方法 |
GB0605880D0 (en) * | 2006-03-24 | 2006-05-03 | Johnson Matthey Plc | Process for producing metal nanoparticles and process for producing gold phenylacetlyides |
-
2008
- 2008-12-26 JP JP2009548115A patent/JP5397862B2/ja not_active Expired - Fee Related
- 2008-12-26 KR KR1020107007479A patent/KR20100107437A/ko not_active Application Discontinuation
- 2008-12-26 US US12/810,764 patent/US20100285994A1/en not_active Abandoned
- 2008-12-26 CN CN200880112617A patent/CN101835556A/zh active Pending
- 2008-12-26 EP EP08867618A patent/EP2241394A1/en not_active Withdrawn
- 2008-12-26 WO PCT/JP2008/073847 patent/WO2009084680A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006059664A1 (ja) * | 2004-12-03 | 2006-06-08 | Japan Science And Technology Agency | 安定化無機ナノ粒子、安定化無機ナノ粒子群、安定化無機ナノ粒子の製造方法及び安定化無機ナノ粒子の利用方法 |
WO2006075974A1 (en) * | 2005-01-17 | 2006-07-20 | Agency For Science, Technology And Research | Water-soluble nanocrystals and methods of preparing them |
JP2007139612A (ja) * | 2005-11-18 | 2007-06-07 | Fujifilm Corp | 微細構造体、微細構造体の作製方法、ラマン分光法、及び装置 |
WO2007107574A2 (fr) * | 2006-03-20 | 2007-09-27 | Commissariat A L'energie Atomique | Nanoparticules notamment a structure coeur coquille, enrobees |
Non-Patent Citations (1)
Title |
---|
成田麻子、中條善樹: ""有機材料による無機ナノ粒子の機能化"", 高分子論文集, vol. 65, no. 5, JPN6013046144, May 2008 (2008-05-01), pages 321 - 333, ISSN: 0002632761 * |
Also Published As
Publication number | Publication date |
---|---|
US20100285994A1 (en) | 2010-11-11 |
CN101835556A (zh) | 2010-09-15 |
JP5397862B2 (ja) | 2014-01-22 |
WO2009084680A1 (ja) | 2009-07-09 |
KR20100107437A (ko) | 2010-10-05 |
EP2241394A1 (en) | 2010-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lv et al. | Stable ICG-loaded upconversion nanoparticles: silica core/shell theranostic nanoplatform for dual-modal upconversion and photoacoustic imaging together with photothermal therapy | |
Dai et al. | Mussel-inspired polydopamine-coated lanthanide nanoparticles for NIR-II/CT dual imaging and photothermal therapy | |
Ai et al. | A core-shell-shell nanoplatform upconverting near-infrared light at 808 nm for luminescence imaging and photodynamic therapy of cancer | |
Li et al. | Dual-stimuli responsive bismuth nanoraspberries for multimodal imaging and combined cancer therapy | |
Liu et al. | An all-in-one theranostic nanoplatform based on upconversion dendritic mesoporous silica nanocomposites for synergistic chemodynamic/photodynamic/gas therapy | |
Yang et al. | A single 808 nm near-infrared light-mediated multiple imaging and photodynamic therapy based on titania coupled upconversion nanoparticles | |
Xiang et al. | A multifunctional nanoplatform for lysosome targeted delivery of nitric oxide and photothermal therapy under 808 nm near-infrared light | |
US9901295B2 (en) | Near infrared fluorescent single walled carbon nanotubes as tissue localizable biosensors | |
Lv et al. | Dopamine-mediated photothermal theranostics combined with up-conversion platform under near infrared light | |
Behboudi et al. | Carbon quantum dots in nanobiotechnology | |
JP5397862B2 (ja) | 金ナノ粒子組成物、dnaチップ、近赤外線吸収材、ドラッグデリバリーシステム(dds)用薬物保持体、着色剤、バイオセンサー、化粧品、生体内診断用組成物および治療用組成物 | |
CN105031647A (zh) | 一种聚多巴胺包裹的聚乙烯亚胺稳定的金纳米星光热治疗剂的制备方法 | |
Odda et al. | Polydopamine coated PB-MnO2 nanoparticles as an oxygen generator nanosystem for imaging-guided single-NIR-laser triggered synergistic photodynamic/photothermal therapy | |
Yang et al. | Synthesis of multifunctional Ag@ Au@ phenol formaldehyde resin particles loaded with folic acids for photothermal therapy | |
Singh et al. | Ultra-bright green carbon dots with excitation-independent fluorescence for bioimaging | |
JP2011016778A (ja) | 金ナノ粒子組成物、dnaチップ、近赤外線吸収材、ドラッグデリバリーシステム(dds)用薬物保持体、着色剤、バイオセンサー、化粧品、生体内診断用組成物および治療用組成物。 | |
CN104027806B (zh) | 一种修饰CuS纳米粒子的介孔二氧化硅包覆四氧化三锰的纳米材料及其制备方法和应用 | |
JP2011016778A5 (ja) | ||
Choi et al. | Dual‐Responsive Carbon Dot for pH/Redox‐Triggered Fluorescence Imaging with Controllable Photothermal Ablation Therapy of Cancer | |
Cai et al. | Integration of Au nanosheets and GdOF: Yb, Er for NIR-I and NIR-II light-activated synergistic theranostics | |
Xue et al. | Rhodamine conjugated gelatin methacryloyl nanoparticles for stable cell imaging | |
KR101582252B1 (ko) | 3차원 구형 거대분자를 이용한 광역학 치료용 고농도 광과민제 합성물 및 그 제조방법 | |
Du et al. | Heterostructures combining upconversion nanoparticles and metal–organic framework: fundamental, classification, and theranostic applications | |
Darrigues et al. | Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment | |
Huang et al. | Deep‐Red to Near‐Infrared Carbon Dots in Biosensing and Bio‐medical Applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111222 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20120117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120118 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20120709 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120710 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130913 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131015 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5397862 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |